Truist Financial Lowers Globus Medical (NYSE:GMED) Price Target to $82.00
Globus Medical (NYSE:GMED – Get Free Report) had its target price dropped by investment analysts at Truist Financial from $90.00 to $82.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the medical device company’s stock. Truist Financial’s price objective indicates a potential upside of 11.79% […]
Globus Medical (NYSE:GMED – Get Free Report) had its target price dropped by investment analysts at Truist Financial from $90.00 to $82.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the medical device company’s stock. Truist Financial’s price objective indicates a potential upside of 11.79% […]
